Mi Mu

3.1k citations

10 papers · 2.0k indexed · 2 hit papers · h-index 8

Impact in

Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Neurology top 1%
- Long-Term Effects of COVID-19

Papers in ⓘ

Immunology and Allergy 1
Infectious Diseases 3
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2

Co-authors: Guogang Xu (4 shared papers)Yingzhen Du (3 shared papers)Tianzhi Li (3 shared papers)Qinyong Hu (2 shared papers)Runsheng Wang (3 shared papers)Chao Hu (3 shared papers)Pengcheng Yang (2 shared papers)Lei Tu (3 shared papers)
Journals: Cancer Management and Research (1 paper)Journal of Autoimmunity (1 paper)Frontiers in Immunology (1 paper)Frontiers in Medicine (1 paper)Hypertension (1 paper)
Partner nations: China United States United Kingdom

In The Last Decade

Mi Mu

10 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study 2020 · 642 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 American Journal of Respiratory and Critical Care Medicine
2020 The American Journal of Gastroenterology

Peers

Countries citing papers authored by Mi Mu

Since Specialization

Citations

This map shows the geographic impact of Mi Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Mu more than expected).

Fields of papers citing papers by Mi Mu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Mu. The network helps show where Mi Mu may publish in the future.

Co-authors

The 25 scholars most cited alongside Mi Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mi Mu Line = papers co-authored together Mi Mu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work
1	Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study The American Journal of Gastroenterology ·Lei Pan, Mi Mu, Pengcheng Yang, Yu Sun, Runsheng Wang, Jun‐Hong Yan, Pibao Li, Baoguang Hu, Jing Wang, Chao Hu, Yuan Jin, Xun Niu, Rongyu Ping, Yingzhen Du, Tianzhi Li, Guogang Xu, Qinyong Hu, Lei Tu Hit paper breakdown →	2020	1234
2	Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study American Journal of Respiratory and Critical Care Medicine ·Yingzhen Du, Lei Tu, Pingjun Zhu, Mi Mu, Runsheng Wang, Pengcheng Yang, Xi Wang, Chao Hu, Rongyu Ping, Peng Hu, Tianzhi Li, Feng Cao, Christopher Chang, Qinyong Hu, Yang Jin, Guogang Xu Hit paper breakdown →	2020	642
3	Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury Journal of Autoimmunity ·Yingzhen Du, Pingjun Zhu, Xi Wang, Mi Mu, Hongxia Li, Yanhong Gao, Xuebing Qin, Yan Wang, Zhijian Zhang, Geping Qu, Guogang Xu, Christopher Chang, Tianzhi Li, Xiangqun Fang, YU Sen-yang	2020	33
4	Role of the IL-33/ST2 axis in cigarette smoke-induced airways remodelling in chronic obstructive pulmonary disease Thorax ·Qiong Huang, Chen Li, Yi Yang, Xiao Qin, Jing Jing Wang, Xin Zhang, Xiao Du, Yang Xia, Ying Wang, Lun Li, Mi Mu, Zhe Lv, Ye Cui, Kewu Huang, Christopher J. Corrigan, Wei Wang, Sun Ying	2021	17
5	The Pathogenesis of Eosinophilic Asthma: A Positive Feedback Mechanism That Promotes Th2 Immune Response via Filaggrin Deficiency Frontiers in Immunology ·Wei Gao, Jiuyu Gong, Mi Mu, Yujin Zhu, Wenjuan Wang, Wen Chen, Guojing Han, Hong Hu, Pengtao Bao	2021	14
6	Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Relapsed/Refractory Small Cell Lung Cancer Patients: Results from a Pilot Study Cancer Management and Research ·Lin Hu, Qin Wang, Fangfang Tian, Rui Zhang, Mi Mu, Weiguo Zhao, Pengtao Bao	2021	12
7	PD-1/PD-L1 Provides Protective Role in Hypoxia-Induced Pulmonary Vascular Remodeling Hypertension ·Lei Wang, Mi Mu, Yu Guo, Jing Huang, Ruoyang Zhang, Muzhi Zhang, Yue Hu, Yanhua Wang, Zhenqiang Gao, Lin Liu, Wang Wang, Yuli Cheng, Xinping Zhu, Jie Liu, Wei Wang, Sun Ying	2024	7
8	Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well- tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion Journal of Thoracic Disease ·Xiaofei Liu, Lin Hu, Qin Wang, Mi Mu, Pan Pan, Fangfang Tian, Rui Zhang, Weiguo Zhao, Pengtao Bao	2021	7
9	Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study European Journal of Clinical Microbiology & Infectious Diseases ·Lei Pan, Runsheng Wang, Na Yu, Chao Hu, Jun‐Hong Yan, Xiaomin Zhang, Tao Wang, Jungui Hao, Fuquan Gao, Tonggang Liu, Jing Wang, Xiaojing Liu, Mi Mu, Wei Huang, Yongzhong Guo, Changjun Lv, Xiaozhi Wang, Lei Tu, Kun Wan, Guogang Xu	2021	6
10	Case report: Rare epithelioid hemangioendothelioma occurs in both main bronchus and lung Frontiers in Medicine ·Jiuyu Gong, Fangfang Tian, Qin Wang, Mi Mu, Sijia Geng, Pengfei Hao, Pengfei Zhong, Rui Zhang, Lin Jiang, Rentao Wang, Pengtao Bao	2022	1

About Mi Mu

Mi Mu is a scholar working on Immunology and Allergy, Infectious Diseases, Neurology, Pulmonary and Respiratory Medicine and Dermatology, having authored 10 papers that have together received 2.0k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Lung Cancer Diagnosis and Treatment (1 paper), IL-33, ST2, and ILC Pathways (1 paper), Pleural and Pulmonary Diseases (1 paper) and Dermatology and Skin Diseases (1 paper). The work is most often cited by research in Infectious Diseases (1.4k citations), Neurology (762 citations), Critical Care and Intensive Care Medicine (102 citations), Applied Microbiology and Biotechnology (31 citations) and Oncology (339 citations). Mi Mu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guogang Xu, Yingzhen Du, Tianzhi Li, Qinyong Hu, Runsheng Wang, Chao Hu, Pengcheng Yang, Lei Tu, Jun‐Hong Yan and Lei Pan. Their work appears in journals such as Cancer Management and Research, Journal of Autoimmunity, Frontiers in Immunology, Frontiers in Medicine and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact